MLchartDataset catalogue

monoclonal antibody HuM195

Term · Oncology and biomedicine · MLC-T-ONC-005489

A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Monoclonal antibody HuM195 is a type of monoclonal antibody. Also called lintuzumab and MoAb HuM195.

Table 1. Record
IdentifierMLC-T-ONC-005489
FieldOncology and biomedicine
Synonymslintuzumab; MoAb HuM195
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005489",
  "term": "monoclonal antibody HuM195",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. Monoclonal antibody HuM195 is a type of monoclonal antibody. Also called lintuzumab and MoAb HuM195.",
  "synonyms": [
    "lintuzumab",
    "MoAb HuM195"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/monoclonal-antibody-hum195/"
}

Record 11,244 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.